Riblet L A, Gatewood C F, Mayol R F
Psychopharmacology (Berl). 1979 May 25;63(2):99-101. doi: 10.1007/BF00429685.
The effect of trazodone, a new antidepressant agent, on uptake of serotonin (5-HT), norepinephrine (NE), and dopamine (DA) by crude synaptosome preparations from rat hypothalamus was compared with imipramine, desipramine, and clomipramine. Trazodone was determined to be a very selective inhibitor of the 5-HT uptake mechanism with IC50 values of 5.67 X 10(-7), 3.54 X 10(-5), and 5.25 X 10(-5 M, for 5-HT, NE, and DA uptake, respectively. Clomipramine, the only other selective inhibitor of 5-HT uptake studied, had IC50 values of 7.59 X 10(-9), 1.12 X 10(-7), and 2.51 X 10(-7) M, for 5-HT, NE, and DA, respectively. Although less potent, trazodone was 4 +/- 0.6 times more selective than clomipramine in its ability to inhibit synaptosomal uptake of 5-HT with respect to NE. This selectivity for the 5-HT uptake mechanism is consistent with the clinical antidepressant efficacy of trazodone.
将新型抗抑郁药曲唑酮与丙咪嗪、地昔帕明和氯米帕明相比较,研究其对大鼠下丘脑粗制突触体中5-羟色胺(5-HT)、去甲肾上腺素(NE)和多巴胺(DA)摄取的影响。结果表明,曲唑酮是一种对5-HT摄取机制具有高度选择性的抑制剂,其对5-HT、NE和DA摄取的IC50值分别为5.67×10^(-7)、3.54×10^(-5)和5.25×10^(-5)M。氯米帕明是所研究的另一种5-HT摄取选择性抑制剂,其对5-HT、NE和DA摄取的IC50值分别为7.59×10^(-9)、1.12×10^(-7)和2.51×10^(-7)M。尽管曲唑酮的效力较低,但其抑制突触体摄取5-HT相对于NE的能力比氯米帕明高4±0.6倍。这种对5-HT摄取机制的选择性与曲唑酮的临床抗抑郁疗效相符。